Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
09/2003
09/25/2003US20030180877 Gene therapy; drug screening
09/25/2003US20030180805 Methods and compositions for derepression of IAP-inhibited caspase
09/25/2003US20030180786 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
09/25/2003US20030180753 Full length human hcn1ih channel subunit and variants
09/25/2003US20030180744 High affinity oligonucleotide ligands to growth factors
09/25/2003US20030180406 Treatment of diseases involving defective gap junctional communication
09/25/2003US20030180404 Methods of treating clinical diseases with isoflavones
09/25/2003US20030180394 Extracts from sophora species, method for producing the same and their use
09/25/2003US20030180362 Multi-stage oral drug controlled-release system
09/25/2003US20030180360 Pharmaceutical compositions of 5,7,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2 (11),3,5,7,9-pentaene
09/25/2003US20030180359 Controlled release
09/25/2003US20030180301 Prevention organ rejection; induction immunology response; reduce fibrosis
09/25/2003US20030180300 Collagen biosynthesis; controlling cell differentiation, cell proliferation
09/25/2003US20030180294 Administering vascular endothelial growth factor receptor inhibitor; supression lymphangiogenesis
09/25/2003US20030180293 Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody
09/25/2003US20030180269 Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
09/25/2003US20030180265 Modulating angiogenesis
09/25/2003CA2828595A1 Use of copper chelating tetraamines for the treatment of cardiovascular disease and heart failure
09/25/2003CA2488928A1 Method of modulating inflammatory response
09/25/2003CA2479676A1 Dexanabinol and dexanabinol analogs regulate inflammation related genes
09/25/2003CA2479620A1 Ethane-1,2-diamino-bis[2r)-2-bromo-3-phenylpropanoate], method for production and use thereof
09/25/2003CA2479352A1 Carboxylic acid compound and a pharmaceutical agent comprising the compound as an active ingredient
09/25/2003CA2479350A1 Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes
09/25/2003CA2479222A1 Use of selective ep4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension
09/25/2003CA2479151A1 Use of proton pump inhibitors for the treatment of noncardiac chest pain
09/25/2003CA2479141A1 Pyridone derivatives
09/25/2003CA2478997A1 Use of copper chelating tetraamines for the treatment of cardiovascular disease and heart failure
09/25/2003CA2478965A1 Agents for corneal or intrastromal administration to treat or prevent disorders of the eye
09/25/2003CA2478803A1 Methods of modulating cd200 receptors
09/25/2003CA2478795A1 Use of rapamycin for inhibiting cell death
09/25/2003CA2478715A1 Novel pyrazolo [1,5-a]pyridine derivatives and their use as neurotransmitter modulators
09/25/2003CA2478653A1 Methods of treatment with selective ep4 receptor agonists
09/25/2003CA2478248A1 Methods and devices for detection and therapy of atheromatous plaque
09/25/2003CA2478172A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
09/25/2003CA2477832A1 Methods of treating diabetes using pde 11a inhibitors
09/25/2003CA2477732A1 Aminomethyl-substituted thiazolobenzimidazole derivatives
09/25/2003CA2476746A1 Difurylglycolic acid tropenol esters used as anticholinesterase drugs
09/24/2003EP1346994A1 Cholesterol biosynthesis inhibitors containing as the active ingredient tricyclic spiro compounds
09/24/2003EP1346992A1 Quinazoline derivatives, process for their preparation and pharmaceutical compositions containing them
09/24/2003EP1346730A1 Pretargeting methods and novel pretargeting conjugates
09/24/2003EP1346728A1 Ophthalmological preparations
09/24/2003EP1346221A1 A method of assaying for agonists or antagonist of dynorphin a binding to the mas receptor
09/24/2003EP1346061A2 Pregnancy-associated plasma protein-a2 (papp-a2)
09/24/2003EP1346056A1 Methods for the production of multimeric proteins, and related compositions
09/24/2003EP1346055A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
09/24/2003EP1346042A2 Fat regulated genes, uses thereof, and compounds for modulating same
09/24/2003EP1346033A2 Novel serine protease genes related to dppiv
09/24/2003EP1346031A2 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof
09/24/2003EP1345968A2 Crystals of whole antibodies and fragments thereof and methods for making and using them
09/24/2003EP1345956A2 Intracellular delivery of biological effectors by novel transporter peptide sequences
09/24/2003EP1345947A1 A new process for preparing fused 1,2,4-thiadiazine derivatives
09/24/2003EP1345946A1 Macroheterocylic compounds useful as kinase inhibitors
09/24/2003EP1345938A1 Tricyclic crf receptor antagonists
09/24/2003EP1345937A1 Quinuclidine carbamate derivatives and their use as m3 antagonists
09/24/2003EP1345935A2 Piperidine derivatives as subtype selective n-methyl-d-aspartate antagonists
09/24/2003EP1345933A2 Process for making substituted 8-arylquinolinium benzenesulfonate
09/24/2003EP1345932A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
09/24/2003EP1345930A2 Pharmaceutical compounds
09/24/2003EP1345929A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345928A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345927A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345926A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345925A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345924A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
09/24/2003EP1345922A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345920A1 Novel sulfamides and their use as endothelin receptor antagonists
09/24/2003EP1345918A1 Chemical compounds
09/24/2003EP1345916A1 Substituted oxazoles and thiazoles as hppar alpha agonists
09/24/2003EP1345914A1 Therapeutic compounds
09/24/2003EP1345909A1 Phenylacetamido-pyrazole derivatives and their use as antitumor agents
09/24/2003EP1345903A1 Crystalline forms of cerivastatin sodium
09/24/2003EP1345902A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
09/24/2003EP1345899A1 Compounds
09/24/2003EP1345895A1 Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
09/24/2003EP1345892A2 Acylaminoalkyl-substituted benzenesulfonamide derivatives
09/24/2003EP1345890A1 Glucagon antagonists/inverse agonists
09/24/2003EP1345627A1 Targeted modification of intracellular compounds
09/24/2003EP1345616A2 Reducing cellular damage in the human body
09/24/2003EP1345609A1 Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mglur 1 antagonists
09/24/2003EP1345607A1 Therapeutic combination of amlodipine and benazepril / benazeprilat
09/24/2003EP1345606A2 Texaphyrin coordination compounds and uses thereof
09/24/2003EP1345605A1 Thermoformable solid pharmaceutical composition for controlled release of perindopril
09/24/2003EP1345601A2 Use of 5-hydroxy and 5-acyloxy-2,3-dihydro-4,6,7-trimethyl-2-benzofuranacetic acids and their esters as agents useful for healing skin lesions and stimulants of angiogenesis
09/24/2003EP1345600A1 New clinical treatment
09/24/2003EP1345598A2 The use of ppar-gamma agonists for treating diseases characterised by neuron degeneration, neuron injury or impaired plasticity
09/24/2003EP1345594A1 Thermoformable solid pharmaceutical composition for controlled release of ivabradine
09/24/2003EP1345567A2 Calcium channel transport polynucleotides, polypeptides, and antibodies
09/24/2003EP1345501A1 Nutritional and therapeutical preparations having antioxidant activity
09/24/2003EP1259512B1 Pteridine compounds for the treatment of psoriasis
09/24/2003EP1242396B1 New p2x 7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases
09/24/2003EP1224186B1 Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation
09/24/2003EP1196419B1 Potassium channel blocking agents
09/24/2003EP1181302B1 Orally active a1 adenosine receptor agonists
09/24/2003EP1150953B1 Indole derivatives and their use as mcp-1 receptor antagonists
09/24/2003EP1124554B1 Pharmaceutical compositions containing tetrahydroisoquinoline compounds
09/24/2003EP1123109B1 Contulakin-g, analogs thereof and uses therefor
09/24/2003EP1095132A4 Methods for implanting cells
09/24/2003EP1051415B1 Benzamide derivatives as vasopressin antagonists
09/24/2003EP1021444B1 3-CARBOXAMIDE DERIVATIVES OF 5H-PYRROLO[2,1-c][1,4]-BENZODIAZEPINES
09/24/2003EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
1 ... 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 ... 1595